NCT00922597View on ClinicalTrials.gov

Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2008

Study Completion Date

September 30, 2011

Conditions
Hemophilia A
Interventions
BIOLOGICAL

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Patients undergoing surgery and receiving continuous infusion with Kogenate Bayer according to local drug information.

Trial Locations (7)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY